by Backoffice | Oct 18, 2023 | Patents
As of the 18th of September 2023, the patent secures C2Cs technological concept for industrial production, upscaling, and distribution of ASC products has been granted in Canada (Patent number: 3000912). The patent “STEM CELL THERAPY BASED ON ADIPOSE-DERIVED STEM...
by Backoffice | Aug 21, 2022 | Patents
As of the 24th of March 2022, the patent secures C2Cs technological concept for industrial production, upscaling, and distribution of ASC products in Australia (Patent number: 2016342387). The patent “STEM CELL THERAPY BASED ON ADIPOSE-DERIVED STEM CELLS” has...
